These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3473157)

  • 1. HTLV-III antibodies in a patient with mycosis fungoides.
    Srivastava BI; Getchell JP; Stoll HL
    J Med; 1986; 17(1):57-63. PubMed ID: 3473157
    [No Abstract]   [Full Text] [Related]  

  • 2. Human T-cell leukemia virus in cutaneous T-cell lymphoma in Denmark. A possible association of HTLV and aneuploidy.
    Lange Wantzin G; Saxinger WC; Woods A; Larsen JK; Thomsen K; Gallo RC
    Acta Derm Venereol; 1984; 64(5):395-9. PubMed ID: 6208717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus antibody titres in mycosis fungoides.
    Hopsu-Havu VK; Nikoskelainen J
    Acta Derm Venereol; 1972; 52(5):346-8. PubMed ID: 4117078
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic abnormalities and antibodies to HTLV-III in asymptomatic drug addicts.
    Ortona L; Laghi V; Tamburrini E; Nervo P; Cauda R
    Ala J Med Sci; 1987 Jan; 24(1):46-51. PubMed ID: 3644604
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-HTLV III antibodies in the personnel of a hospital in the Campania region].
    Ferro V; Sapia P; Perna C; Salvi MP; Piscopo V
    Quad Sclavo Diagn; 1986 Mar; 22(1):104-9. PubMed ID: 3641325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological profile of drug addicts: HTLV-III negative, HTLV-III positive and those with lymphadenopathy syndrome-AIDS related complex].
    Cascavilla N; Martini E; Melillo L; Musto P; Nobile M; Valori VM; Di Giorgio G; Carotenuto M
    Recenti Prog Med; 1987 Mar; 78(3):108-12. PubMed ID: 3648856
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mycosis fungoides in a Gabonese patient infected with HTLV-I].
    Perret JL; Moussavou-Kombila JB; Delaporte E; Coniquet S; Nguemby-Mbina C; Normand P
    Med Trop (Mars); 1996; 56(1):66-8. PubMed ID: 8767797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTLV-I-related retroviral markers in Hungarian patients with mycosis fungoides.
    Kiss J; Tisza T; Tóth FD; Horváth A; Stumpf A
    Acta Microbiol Hung; 1993; 40(2):123-30. PubMed ID: 8184667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence of HTLV-I infection in patients with mycosis fungoides and Sezary syndrome.
    Pawlaczyk M; Filas V; Sobieska M; Gozdzicka-Józefiak A; Wiktorowicz K; Breborowicz J
    Neoplasma; 2005; 52(1):52-5. PubMed ID: 15739027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basaloid folliculolymphoid hyperplasia: a distinctive finding in follicular mycosis fungoides.
    Gerami P; Guitart J
    J Cutan Pathol; 2007 Dec; 34 Suppl 1():29-32. PubMed ID: 17997735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serological survey on the prevalence of anti-HTLV-III antibodies in a psychiatric hospital].
    Antila CC; Blotta MH; Gomes MC
    Rev Paul Med; 1986; 104(6):328. PubMed ID: 3650926
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients.
    Jumbou O; Mollat C; N'Guyen JM; Billaudel S; Litoux P; Dréno B
    Br J Dermatol; 1997 Feb; 136(2):212-6. PubMed ID: 9068734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of anti-HTLV-III antibodies in volunteer blood donors in Guipuzcoa].
    Cortés A; Francisco C; Larrañaga MJ; Cárdenas JM
    Med Clin (Barc); 1987 Jan; 88(1):38-9. PubMed ID: 3644127
    [No Abstract]   [Full Text] [Related]  

  • 14. [Analysis of antibodies to human T-lymphotropic type III virus (anti-HTLV III) in a population at high risk for AIDS in Yugoslavia].
    Burek V; Sakoman S; Hudolin V; Kovać D; Ficović P; Cepelja Z; Petricević I; Schönwald S; Soldo I; Borcić D
    Lijec Vjesn; 1987 Jun; 109(6):216-9. PubMed ID: 3477674
    [No Abstract]   [Full Text] [Related]  

  • 15. Significance of anti-HTLV-III testing of volunteer blood donors.
    Grindon AJ
    Beitr Infusionther Klin Ernahr; 1987; 18():1-5. PubMed ID: 3326580
    [No Abstract]   [Full Text] [Related]  

  • 16. [Visceral leishmaniasis associated with positive anti-HTLV III antibody].
    Verdejo J; Alvar J; Polo RM; González Lahoz JM
    Rev Clin Esp; 1987 Mar; 180(4):221. PubMed ID: 3647541
    [No Abstract]   [Full Text] [Related]  

  • 17. [Conjugal mycosis fungoides].
    Dupin M; Darie H; Jumbou O; Veran Y; Gros P; Dreno B; Dormont D; Millet P
    Ann Dermatol Venereol; 1995; 122(9):595-8. PubMed ID: 8745682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies anti-HTLV III and lymphocyte subsets of high risk subjects.
    Ripa S; Mignini F; Anichini M; Casprini P; Prenna M
    Boll Ist Sieroter Milan; 1987; 66(2):101-5. PubMed ID: 3663335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing antibodies in HIV (HTLV-III) infection: correlation with clinical outcome and antibody response against different viral proteins.
    Ranki A; Weiss SH; Valle SL; Antonen J; Krohn KJ
    Clin Exp Immunol; 1987 Aug; 69(2):231-9. PubMed ID: 3652531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
    Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.